Print Issue: August 01, 2008

Lower BP Goal in Black CKD Patients

NEW ORLEANS—An extended follow-up of patients in the African American Study of Kidney Disease (AASK) confirms that ACE inhibitors work better than amlodipine in treating nondiabetic hypertensive CKD in black patients.

Insurers Should Cover Post-Op ED Treatment

ORLANDO—Men who experience erectile dysfunction (ED) following prostate cancer surgery usually do not have coverage for ED treatment even though their insurance policies cover surgery for prostate cancer, according to a study.

Fixed-Dose Combination Tablet Approved for Type 2 Diabetes

Sciele Pharma, Inc., of Atlanta and Novo Nordisk Inc., of Denmark, have announced approval for PrandiMet (repaglinide and metformin HCl) tablets, the first and only fixed-dose combination of the fast-acting secretagogue replaglinide (also called Prandin) and the insulin sensitizer metformin for the treatment of type 2 diabetes.

Next post in FDA News